Vaccine Forum

GBC 2

Vaccine Forum

09:00 ~ 18:00 GB I 5F

Summary
A vaccine contains materials originated from living organisms and is used to prevent infectious diseases. We provide the latest information on its development strategies and life-cycle safety managements from diverse global companies and regulators.
Date
June 28(Thu), 09:00 ~ 18:00
Venue
GB I 5F Venue Guide

Schedule

Time Title Presentation File
Vaccine
[Session 1] Vaccine Development Strategy | Chair : Jin-Han Kang (Seoul St’ Mary Hospital)
09:00~09:50(50')

[Keynote Speech] Advisory view of WHO on Vaccine development and the policy of Korea

Francois-Xavier Lery / WHO

09:50~10:40(50')

[Keynote Speech] A New Era for Vaccines against Emerging Infectious Diseases

Richard Hatchett / CEPI

10:40~11:00(20')

Coffee Break

-
11:00~11:50(50')

Regulatory Challenges for the Licensure of Future Vaccines

Tong Wu / Health Canada

11:50~12:40(50')

The Dengue Experience and implication in the vaccine development strategy

In-Kyu Yoon / International Vaccine Institute

12:40~12:50(10')

Q & A

-
[Session 2] Vaccine Life Cycle Management | Chair : Yeowon Sohn (Seoul National University)
14:20~15:10(50')

“A Change is Gonna Come” – Life Cycle Management of Vaccine Quality-A Framework to Ensure Consistent Vaccine Quality Subsequent to Post-Approval CMC Changes

Ralf Josef Wagner / PEI

15:10~16:00(50')

Examples of Global Post Authorization Safety Studies

Yanfang Liu / Janssen

16:00~16:10(10')

Q & A

-
16:10~16:30(20')

Coffee Break

-
16:30~17:10(40')

Vaccine post approval safety management

Veronica Urdaneta / Merck Sharp & Dohme

17:10~17:50(40')

Post-approval CMC changes with matrix approach

Barbara Harrison / GSK Vaccines

17:50~18:00(10')

Q & A

-